Treatment evaluation criteria are essential for assessing the effectiveness of cancer therapies. These guidelines typically include: - Response Evaluation Criteria in Solid Tumors (RECIST): Criteria for measuring tumor size and response to treatment. - Overall Survival (OS): The length of time from diagnosis or start of treatment that patients are still alive. - Progression-Free Survival (PFS): The length of time during and after treatment that a patient lives with the disease without it getting worse. - Quality of Life (QoL): Assessment of the patient's overall well-being, considering physical, emotional, and social factors.
